TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Double Blind Pragmatic Randomised Controlled Trial (BOAT)

Pharmaceutical products
North East (UKC2)
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Newcastle Upon Tyne Hospitals NHS Foundation Trust: "Double Blind Pragmatic Randomised Controlled Trial (BOAT)". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityThe Newcastle Upon Tyne Hospitals NHS Foundation TrustScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: The Newcastle Upon Tyne Hospitals NHS Foundation Trust
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for The Newcastle Upon Tyne Hospitals NHS Foundation Trust. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
2.3Bids / Report
50% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 29 active published awards; 24 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityThe Newcastle Upon Tyne Hospitals NHS Foundation Trust
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published30 Oct 2024, 09:37 GMT
Last source update30 Oct 2024, 09:37 GMT
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
North East (UKC2)
OCIDocds-h6vhtk-046e40
What is being bought
The Newcastle Upon Tyne NHS Foundation Trust has awarded a contract for the Provision of a Double Blind Pragmatic Randomised Controlled Trial: Bronchiectasis Optimising Azithromycin prevention Treatment to reduce exacerbations (BOAT) via open procedure to the supplier Eramol for 24 months with the option to extend for a further 12 months.
What changed
From the official release history
  1. tender value changed
    30 Oct 2024, 09:37 GMT
  2. Status changed to complete
    30 Oct 2024, 09:37 GMT
  3. Official notice release published
    30 Oct 2024, 09:37 GMT
  4. Submission deadline changed to published date
    30 Oct 2024, 09:37 GMT
  5. Published value updated to £300,000
    7 Jun 2024, 11:29 BST
  6. Status changed to active
    7 Jun 2024, 11:29 BST
  7. Official notice release published
    7 Jun 2024, 11:29 BST
  8. Submission deadline changed to 24 Jun 2024, 12:00 BST
    7 Jun 2024, 11:29 BST
  9. Buyer information updated
    7 Jun 2024, 11:29 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    The Trust undertakes clinical trials within the main pharmacy departments with the responsibility for coordinating the dispensing process for the numerous commercial and non-commercial clinical trials conducted throughout the Newcastle Hospitals. The Pharmacy departing is currently reviewing the uncertainty about how best to use long-term antibiotics in people with Bronchiectasis to reduce the risk of future exacerbations.<br/>Although guidelines are consistent in recommending azithromycin as the prophylactic antibiotic of choice, there are distinct differences between them, notably in eligibility criteria for azithromycin chemoprophylaxis, dose, and duration of treatment.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    30 Oct 2024, 09:37 GMT
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 20 Sept 2024, 00:00 BST · £312,355
Commercial outcome and competition
Awards
Eramol (UK) Ltd
Not published · Not published · active
Contracts
Contract
£312,355 · signed 20 Sept 2024, 00:00 BST · active
Bid statistics
bids: 2 (lot 1)
electronicBids: 2 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
smeBids: 0 (lot 1)
Buyer and organisations in this procedure

The Newcastle Upon Tyne Hospitals NHS Foundation Trust

Contracting authority GB-FTS-79645
View buyer profile

  • The Newcastle Upon Tyne Hospitals NHS Foundation Trust
    buyer

    Regent Point, NEWCASTLE UPON TYNE, UKC22, NE7 7DN
    rebecca.dexter@nhs.net
    +44 1912137523

  • Eramol (UK) Ltd
    supplier

    08681617
    Unit 9 North Downs Business Park, Limepit Lane, Sevenoaks, Kent, England, TN13 2TL, Sevenoaks, UKC22, TN13 2TL
    +44 7909211181

  • The Newcastle Upon Tyne Hospitals NHS Foundation Trust
    reviewBody

    Freeman Hospital, Freeman Road, High Heaton, Newcastle-upon-Tyne,  NE7 7DN
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published